NEW YORK, Nov. 1 – German pharmaceutical company Altana has agreed to make an equity investment of 34.2 million euros ($31.1 million) in GPC Biotech, GPC said Thursday.

GPC of Munich said it would issue 1.69 million of its shares to Altana at 20.25 euros a share. Following the transaction, Altana will hold an 8.3 percent stake in GPC, making it the second largest shareholder in the company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.